IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.333
EU - Europa 3.766
NA - Nord America 2.976
SA - Sud America 1.221
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 12.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.834
RU - Federazione Russa 2.392
SG - Singapore 1.753
CN - Cina 1.212
BR - Brasile 995
HK - Hong Kong 534
SE - Svezia 526
VN - Vietnam 435
IT - Italia 248
FR - Francia 211
DE - Germania 113
GB - Regno Unito 88
AR - Argentina 87
BD - Bangladesh 83
IN - India 67
CA - Canada 63
MX - Messico 45
EC - Ecuador 44
ID - Indonesia 35
FI - Finlandia 31
TR - Turchia 29
IQ - Iraq 27
IE - Irlanda 26
JP - Giappone 26
CO - Colombia 25
PY - Paraguay 25
PL - Polonia 23
ZA - Sudafrica 21
AT - Austria 20
NL - Olanda 19
UZ - Uzbekistan 19
ES - Italia 17
LT - Lituania 14
PE - Perù 14
PK - Pakistan 14
UA - Ucraina 13
CL - Cile 11
MA - Marocco 11
TN - Tunisia 11
IR - Iran 10
SA - Arabia Saudita 10
EG - Egitto 9
MY - Malesia 9
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
JO - Giordania 7
PH - Filippine 7
UY - Uruguay 7
JM - Giamaica 6
KE - Kenya 6
NP - Nepal 6
AZ - Azerbaigian 5
ET - Etiopia 5
IL - Israele 5
OM - Oman 5
EU - Europa 4
GT - Guatemala 4
KW - Kuwait 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KZ - Kazakistan 3
MD - Moldavia 3
SC - Seychelles 3
AM - Armenia 2
BE - Belgio 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
GY - Guiana 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
NI - Nicaragua 2
QA - Qatar 2
SN - Senegal 2
SR - Suriname 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
Totale 12.373
Salva come PNG Salva come JPEG
Città #
Dallas 710
Singapore 674
Moscow 555
Hong Kong 527
San Jose 357
Ashburn 320
Shanghai 290
Hefei 212
Princeton 192
Lawrence 191
Lauterbourg 181
Ho Chi Minh City 152
New York 116
Beijing 97
Hanoi 96
São Paulo 84
Milan 65
Los Angeles 56
Santa Clara 41
Orem 32
Da Nang 31
Boardman 29
Brooklyn 28
Brasília 26
Nuremberg 26
Dublin 25
Belo Horizonte 24
Chennai 24
Haiphong 24
Helsinki 24
Rio de Janeiro 23
Munich 20
London 19
Rome 19
Denver 18
Guangzhou 18
Houston 18
Tashkent 18
Warsaw 18
Mexico City 16
Montreal 16
Porto Alegre 16
Tokyo 16
Chicago 15
Johannesburg 15
Quito 15
Salvador 15
Biên Hòa 14
Frankfurt am Main 14
Guayaquil 14
Brescia 13
Hangzhou 13
Phoenix 13
The Dalles 13
Council Bluffs 12
Curitiba 12
Manchester 12
Atlanta 11
Boston 11
Mumbai 11
Bogotá 10
Changsha 10
Sorocaba 10
Stockholm 10
Toronto 10
Ankara 9
Campinas 9
Fortaleza 9
Guarulhos 9
Lima 9
Poplar 9
São Bernardo do Campo 9
Buenos Aires 8
Dhaka 8
Hải Dương 8
Istanbul 8
Recife 8
Uberlândia 8
Vienna 8
Amsterdam 7
Columbus 7
Durham 7
Goiânia 7
Naples 7
São Gonçalo 7
Vancouver 7
Amman 6
Assago 6
Buffalo 6
Cabo Frio 6
Caxias do Sul 6
Erbil 6
Itaquaquecetuba 6
Jakarta 6
Kuala Lumpur 6
Marília 6
Montevideo 6
Ninh Bình 6
San Francisco 6
São Vicente 6
Totale 5.969
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 225
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 143
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
[New therapeutic options for the treatment of tricuspid regurgitation] 136
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 132
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 126
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 113
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 112
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 109
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 105
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 104
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 103
Diabetes and mortality in patients with COVID-19: Are we missing the link? 102
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 102
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 99
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 99
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 97
A new tool for the forgotten valve: a score to predict the risk of surgery 95
[40 Years of coronary angioplasty: success comes from skills and determination!] 94
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 94
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 93
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 92
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 91
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 91
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 91
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 90
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 90
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 88
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 87
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 86
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 84
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 84
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 84
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 83
Advances in percutaneous interventional therapies: The tricuspid valve 79
Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry 78
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 76
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 76
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 74
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 72
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 72
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 71
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 71
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 70
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 70
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 70
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 69
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 69
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 68
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 68
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 68
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 67
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 67
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 67
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 67
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 67
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 65
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 65
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 64
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 64
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 63
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 62
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 62
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 61
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 61
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 60
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 60
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 60
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 60
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 60
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 60
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 59
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? 59
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 58
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 58
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 58
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 58
Subclinical Leaflet Thrombosis After Transcatheter Mitral Valve-in-Ring Implantation 58
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 58
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 57
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 57
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 57
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 57
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 57
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 57
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 57
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 57
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 57
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 56
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 56
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 56
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 55
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 55
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 54
Outcomes in coronary stents trials - 1 year is not enough 54
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation 54
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 54
Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature 54
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 54
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort 54
Totale 7.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202299 5 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/20252.582 386 23 16 59 63 209 361 186 452 293 257 277
2025/20268.328 503 786 919 1.288 581 188 680 491 2.147 356 223 166
Totale 12.678